KABRADG exchange filings, corporate actions and results
3 Sep 2026
⚑ Filing
Kabra Drugs Ltd - 524322 - Book Closure And Schedule Of Events For E-Voting.BSE filing · raw filing ↗
2 Sep 2026
⚑ Filing
Kabra Drugs Ltd - 524322 - Appointment Of Internal Auditor Of The CompanyBSE filing · raw filing ↗
2 Sep 2026
⚑ Filing
Kabra Drugs Ltd - 524322 - Appointment Of Secretarial Auditor Of The CompanyBSE filing · raw filing ↗
2 Sep 2026
⚑ Filing
Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On 02Nd September 2026BSE filing · raw filing ↗
29 Aug 2026
⚑ Filing
Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Change in Registered Office AddressBSE filing · raw filing ↗
27 Aug 2026
⚑ Filing
Kabra Drugs Ltd - 524322 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 02Nd September 2026BSE filing · raw filing ↗
18 Aug 2026
⚑ Filing
Kabra Drugs Ltd - 524322 - Reconstitution Of The Composition Of The Board & Committees Of Regulation 30 Of SEBI (LODR) Regulations, 2015BSE filing · raw filing ↗
18 Aug 2026
⚑ Filing
Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
12 Aug 2026
⚑ Filing
Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE filing · raw filing ↗
12 Aug 2026
⚑ Filing
Kabra Drugs Ltd - 524322 - Undertaking For Non- Applicability Of Regulation 32 Of SEBIBSE filing · raw filing ↗
12 Aug 2026
⚑ Result
Q1 FY27 results filed — revenue ₹46 Cr (−NaN% YoY), PAT ₹2 Cr (−NaN% YoY)BSE filing · raw filing ↗
12 Aug 2026
⚑ Filing
Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August 2026BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
